NNVC

NANOVIRICIDES, INC.

Healthcare · Biotechnology

$135.55 sample

+0.81 (+0.60%) 1D

Market cap

$503.1B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-17

Alerts

8

Price$135.55 +3.66% 3M daily closessample

138.05128.24

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06INSInsider sell: Chief Executive Officer
Sep 28INSInsider sell: Chief Executive Officer
Sep 17SECForm 144 filed
Sep 11SEC10-Q filed
Sep 08SECDEF 14A filed
Aug 28SEC8-K filed: material event
Aug 24SEC8-K filed: material event
Aug 17INSInsider sell: EVP, Operations

Sign up to see the real NNVC record →

Company facts

SEC EDGAR registration

Name: NANOVIRICIDES, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -3sample, -100 to +100
Reporting currency: USD

Who is positioning in NNVC

sample

Insiders: 7 insider transactions over 90 days, net selling, $110.9M
Congress: 4 members traded over 90 days
Institutions · 13F: 15 funds hold $5.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$28.6B +14.9% y/y

Q4 2024Q3 2026

Inventory$16.6B +14.4% y/y

Q4 2024Q3 2026

Accounts receivable$13.0B +13.1% y/y

Q4 2024Q3 2026

Total debt$35.3B +10.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $448.8B +13.6% 3M
Sample peer B: $423.7B +15.9% 3M
Sample peer C: $73.2B -4.7% 3M
Sample peer D: $377.8B +9.7% 3M
Sample peer E: $430.3B +15.0% 3M